Sanara Medtech Inc reports results for the quarter ended in September - Earnings Summary

Sanara MedTech

15/11/2022 01:37

* Sanara Medtech Inc  SMTI.OQ  reported a quarterly adjusted
loss
of 18 cents​​ per share for the quarter ended in September. The
lone analyst forecast for the quarter was for a loss of 32 cents
per share.
    * Revenue rose 124% to $13.04 million from a year ago;
analysts
expected $14.70 million. 
    * Sanara Medtech Inc's reported EPS for the quarter was a
loss
of 18 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Sanara Medtech Inc shares had risen by 17.7% this
quarter and
gained 18.3% so far this year.
    * The company reported a quarterly loss of $1.47 million.
    * Wall Street's median 12-month price target for Sanara
Medtech
Inc is $50.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
15 at 01:37 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.32          -0.18          Beat
 Jun. 30 2022      -0.28          -0.42          Missed
 Dec. 31 2021      -0.27          -0.48          Missed